Alport syndrome and thin glomerular basement membrane nephropathy a practical approach to diagnosis

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 2, 2009, Pages 224-232

  Haas, Mark ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA3 CHAIN; COLLAGEN TYPE 4 ALPHA5 CHAIN; UNCLASSIFIED DRUG;

ALPORT SYNDROME; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTRON MICROSCOPY; FAMILY; GENE LOCUS; GENE MUTATION; GENETIC DISORDER; GENETIC VARIABILITY; GLOMERULUS BASEMENT MEMBRANE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOLOGY; KIDNEY BIOPSY; KIDNEY DISEASE; MUTATION; REVIEW; SKIN BIOPSY; THIN GLOMERULAR BASEMENT MEMBRANE NEPHROPATHY;

AUTOANTIGENS; COLLAGEN TYPE IV; DIAGNOSIS, DIFFERENTIAL; GLOMERULAR BASEMENT MEMBRANE; GLOMERULONEPHRITIS; HUMANS; MUTATION; NEPHRITIS, HEREDITARY;

EID: 60149106148     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Gubler M, Levy M, Broyer M, et al. Alport's syndrome: a report of 58 cases and a review of the literature. Am J Med. 1981;70:493-505.
2. Feingold J, Bois E, Chompret A, Broyer M, Gubler MC, Grunfeld JP. Genetic heterogeneity of Alport syndrome. Kidney Int. 1985;27:672-677.
3. Hasstedt SJ, Atkin CL, San Juan AC. Genetic heterogeneity among kindreds with Alport syndrome. Am J Human Genet. 1986;38:940-953.
4. Kashtan CE, Michael AF. Alport syndrome. Kidney Int. 1996;50:1445-1463.
5. Wester DC, Atkin CL, Gregory MC. Alport syndrome: clinical update. J Am Acad Audiol. 1995;6:73-79.
6. Chance JK, Stanley JA. Alport's syndrome: case report and review of ocular manifestations. Ann Ophthalmol. 1977;9:1527-1530.
7. Nielsen CE. Lenticonus anterior and Alport's syndrome. Arch Ophthalmol. 1978;56:518-530.
8. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003;348:2543-2556.
9. Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol. 1998;9:1736-1750.
10. Meleg-Smith S, Magliato S, Cheles M, Garola RE, Kashtan CE. X-Linked Alport syndrome in females. Hum Pathol. 1998;29:404-408.
11. Gubler MC, HeidetL, Antignac C. Alport's syndrome, thin basementmembrane nephropathy, nail-patella syndrome, and type III collagen glomerulopathy. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstalls Pathology of the Kidney. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2007:487-515.
12. 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet. 1994;3:1269-1273.
13. 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet. 1994;8:77-81.
14. Heidet L, Arrondel C, Forestier L, et al. Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol. 2001;12:97-106.
15. 4 genes (COL4A3 and COL4A4). Nephrol Dial Transplant. 1997;12:1595-1 599.
16. 44(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolemia. Nephrol Dial Transplant. 2001;16:2008-2012.
17. van der Loop FTL, Heidet L, Timmer EDJ, et al. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int. 2000;58:1870-1875.
18. Dagher H, Buzza M, Colville D, et al. A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome. Am J Kidney Dis. 2001;38:1217-1228.
19. Liapis H, Gokden N, Hmiel P, Miner JH. Histopathology, ultrastructure, and clinical phenotypes in thin glomerular basement membrane disease variants. Hum Pathol. 2002;33:836-845.
20. Nieuwhof CMG, de Heer F, de Leeuw P, van Breda Vriesman PJC. Thin GBM nephropathy: premature glomerular obsolescence is associated with hypertension and late onset renal failure. Kidney Int. 1997;51:1596-1601.
21. 4 gene. J Clin Invest. 1996;98:1114-1118.
22. Buzza M, Wang YY, Dagher H, et al. COL4A4 mutation in thin glomerular basement membrane disease previously described in Alport syndrome. Kidney Int. 2001;60:480-483.
23. Savage J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY. Thin basement membrane nephropathy. Kidney Int. 2003;64:1169-1178.
24. Piccini M, Casari G, Zhou J, et al. Evidence for genetic heterogeneity in benign familial hematuria. Am J Nephrol. 1999;19:464-467.
25. Voskarides K, Damianou L, Neocleous V, et al. COLA3/COLA4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J Am Soc Nephrol. 2007;18:3004-3016.
26. Haas M. Thin glomerular basement membrane nephropathy: incidence in 3471 consecutive renal biopsies examined by electron microscopy. Arch Pathol Lab Med. 2006;130:699-706.
27. Dische FE. Measurement of glomerular basement membrane thickness and its application to the diagnosis of thin-membrane nephropathy. Arch Pathol Lab Med. 1992;116:43-49.
28. Hirose K, Osterby R, Nozawa M, Gundersen HJG. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int. 1982; 21:689-695.
29. Tiebosch ATMG, Frederik PM, van Breda Vriesman PJC, et al. Thin-basement-membrane nephropathy in adults with persistent hematuria. N Engl J Med. 1989;320:14-18.
30. McLay ALC, Jackson R, Meyboom F, Boulton Jones JM. Glomerular basement membrane thinning in adults: clinicopathological correlations of a new diagnostic approach. Nephrol Dial Transplant. 1992;7:191-199.
31. Das AK, Pickett TM, Tungekar MF. Glomerular basement membrane thickness-a comparison of two methods of measurement in patients with unexplained hematuria. Nephrol Dial Transplant. 1996;11:1256-1260.
32. Abe S, Amagasaki Y, Iyori S, et al. Thin basement membrane syndrome in adults. J Clin Pathol. 1987;40:318-322.
33. Foster K, Markowitz GS, D'Agati VD. Pathology of thin basement membrane nephropathy. Semin Nephrol. 2005;25:149-158.
34. Berthoux FC, Laurent B, Alamartine E, Diab N. New subgroup of primary IgA nephritis with thin glomerular basement membrane (GBM): syndrome or association. Nephrol Dial Transplant. 1996;11:558-559.
35. Taguchi T, von Bassewitz DB, Grundmann E, Takebayashi S. Ultrastructural changes of glomerular basement membrane in IgA nephritis: relationship to hematuria. Ultrastruct Pathol. 1 988;12:17-26.
36. Fioretto P, Steffes MW, Brown DM, Mauer SM. An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics. Am J Kidney Dis. 1992;20:549-558.
37. Morita M, White RHR, Raafat F, Barnes JM, Standring DM. Glomerular basement membrane thickness in children: a morphometric study. Pediatr Nephrol. 1988;2:190-195.
38. Vogler C, McAdams AJ, Homan SM. Glomerular basement membrane and lamina densa in infants and children: an ultrastructural evaluation. Pediatr Pathol. 1987;7:527-534.
39. Yoshikawa N, Matsuyama S, Iijima K, Maehara K, Okada S, Matsuo T. Benign familial hematuria. Arch Pathol Lab Med. 1988;112:794-797.
40. Gubler MC, Beaufils H, Noel LH, Habib R. Significance of thin glomerular basement membranes in hematuric children. Contrib Nephrol. 1990;80:147-156.
41. Cosio FG, Falkenhain ME, Sedmak DD. Association of thin glomerular basement membrane with other glomerulopathies. Kidney Int. 1994;46:471-474.
42. Nogueira M, Cartwright J Jr, Horn K, et al. Thin basement membrane disease with heavy proteinuria or nephrotic syndrome at presentation. Am J Kidney Dis. 2000;35:E15.
43. van Paassen P, van Breda Vriesman PJC, van Rie H, Cohen Tervaert JW. Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-the Limburg Renal Registry. Kidney Int. 2004;66:909-913.
44. Ng WL, Chan KW, Yeung CK, Kwan S. Peripheral glomerular capillary wall lesions in IgA nephropathy and their implications. Pathology. 1984;16:324-330.
45. Yoshikawa N, Yoshihara S, Yoshiya K, Matsuo T, Okada S. Lysis of the glomerular basement membrane in children with IgA nephropathy and Henoch-Shonlein nephritis. J Pathol. 1986;150:119-126.
46. Gubler M, Levy M, Broyer M, et al. Alport's syndrome: a report of 58 cases and a review of the literature. Am J Med. 1981;70:493-505.
47. Krickstein HI, Gloor FJ, Balogh K Jr. Renal pathology in hereditary nephritis with nerve deafness. Arch Pathol. 1966;82:506-517.
48. Yoshikawa N, White RHR, Cameron AH. Familial hematuria: clinico-pathological correlations. Clin Nephrol. 1982;17:172-182.
49. Hinglais N, Grunfeld JP, Bois E. Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome). Lab Invest. 1972;27:473-487.
50. Rumpelt HJ. Hereditary nephropathy (Alportsyndrome): correlation ofclin- ical data with glomerular basement membrane alterations. Clin Nephrol. 1980;13:203-207.
51. Mazzucco G, Barsotti P, Muda AO, et al. Ultrastructural and immunohis-tochemical findings in Alport's syndrome: a study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J Am Soc Nephrol. 1998;9:1023-1031.
52. Nadasdy T, Abdi R, Pitha J, Slakey D, Racusen L. Diffuse glomerular basement membrane lamellation in renal allografts from pediatric donors to adult recipients. Am J Surg Pathol. 1999;23:437-442.
53. Hill GS, Jenis EH, Goodloe S Jr. The nonspecificity of the ultrastructural alterations in hereditary nephritis with additional observations on benign familial hematuria. Lab Invest. 1974;31:516-532.
54. Nakanishi K, Yoshikawa N, Iijima K, et al. Immunohistochemical study of alpha 1-5 chains of type IV collagen in hereditary nephritis. KidneyInt. 1994;46:1413-1421.
55. 5 chain: normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol. 1994;144:986-996.
56. van der Loop FTL, Monnens LAH, Schroder CH, et al. Identification of COL4A5 defects in Alport's syndrome by immunohistochemistry of skin. Kidney Int. 1999;55:1217-1224.
57. 2(IV) chain coexpression: analysis of skin biopsies of Alport
58. patients. Kidney Int. 2007;72:512-516.
59. Gubler MC, Knebelmann B, Beziau A, et al. Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int. 1995;47:1142-1147.